New Drug: Dostarlimab-gxly for dMMR endometrial cancer
|New Drug: Dostarlimab-gxly for dMMR endometrial cancer|
BMJ 2022, 10 (1)
Oaknin A et al. ¨Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer l ¨
Reviewed by Elvin CHALABİYEV, MD on FEB 24, 2023
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.